Lymph Node Dissection in the Management of Renal Cell Carcinoma

Urologic Clinics of North America

Volumn 35, Issue 4, 2008, Pages 673-678

  Leibovich, Bradley C ^a   Blute, Michael L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Carcinoma, renal cell; Kidney neoplasms; Lymph node excision; Nephrectomy

Indexed keywords

CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; KIDNEY CARCINOMA; KIDNEY PELVIS CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; MICROMETASTASIS; NEPHRECTOMY; NEPHRON SPARING SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT INDICATION;

CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; NEPHRECTOMY; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT;

EID: 55049097141     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2008.07.011     Document Type: Review

References (25)

1. Robson C.J., Churchill B.M., and Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 101 (1969) 297-301
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
3. Garcia J.A., and Rini B.I. Recent progress in the management of advanced renal cell carcinoma. CA Cancer J Clin 57 (2007) 112-125
4. Pantuck A.J., Zisman A., Dorey F., et al. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Cancer 97 (2003) 2995-3002
5. Frank I., Blute M.L., Cheville J.C., et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168 (2002) 2395-2400
6. Leibovich B.C., Blute M.L., Cheville J.C., et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97 (2003) 1663-1671
7. Leibovich B.C., Cheville J.C., Lohse C.M., et al. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol 174 (2005) 1759-1763 [discussion: 1763]
8. Pantuck A.J., Zisman A., Dorey F., et al. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 169 (2003) 2076-2083
9. Blom J.H., van Poppel H., Marechal J.M., et al. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group. Eur Urol 36 (1999) 570-575
10. Leibovich B.C., Blute M.L., Cheville J.C., et al. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 171 (2004) 1066-1070
11. Thompson R.H., Boorjian S.A., Lohse C.M., et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 179 (2008) 468-471 [discussion: 472-3]
12. Wood Jr. D.P. Role of lymphadenectomy in renal cell carcinoma. Urol Clin North Am 18 (1991) 421-426
13. Mortensen H. Transthoracic nephrectomy. J Urol 60 (1948) 855-858
14. Robson C.J. Radical nephrectomy for renal cell carcinoma. J Urol 89 (1963) 37-42
15. Parker A. Studies on the main posterior lymph channels of the abdomen and their connections with the lymphatics of the genito-urinary system. Am J Anat 56 (1935) 409-443
16. Saksena M.A., Saokar A., and Harisinghani M.G. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging. Eur J Radiol 58 (2006) 367-374
17. Terrone C., Guercio S., De Luca S., et al. The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 91 1 (2003) 37-40
18. Studer U.E., Scherz S., Scheidegger J., et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 144 (1990) 243-245
19. Herrlinger A., Schrott K.M., Schott G., et al. What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma. J Urol 146 (1991) 1224-1227
20. Phillips E., and Messing E. Role of lymphadenectomy in the treatment of renal cell carcinoma. Urology 41 (1993) 9-15
21. Schafhauser W., Ebert A., Brod J., et al. Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy. Anticancer Res 19 (1999) 1573-1578
22. Minervini A., Lilas L., Morelli G., et al. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery?. BJU Int 88 (2001) 169-172
23. Canfield S.E., Kamat A.M., Sanchez-Ortiz R.F., et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol 175 (2006) 864-869
24. Boorjian S.A., Crispen P.L., Lohse C.M., et al. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. J Urol 180 1 (2008) 99-103
25. Blute M.L., Leibovich B.C., Cheville J.C., et al. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 172 (2004) 465-469